LDL apheresis and its effect on viscosity

Cardiovascular Reviews and Reports

Volumn 24, Issue 6, 2003, Pages 321-325+330

  Moriarty, Patrick M ^a   Gibson, Cheryl A ^b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ANTICOAGULATION; APHERESIS; BLOOD FLOW; BLOOD VISCOSITY; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY BLOOD FLOW; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; FLOW KINETICS; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOADSORPTION; MICROVASCULATURE; PLASMA VOLUME; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

EID: 0037905532     PISSN: 01973118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Malek A, Alper S, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA. 1999;282:2035-2042.
2. Lowe G, Lee A, Rumley A, et al. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Brit J Hematol. 1997;96:168-173.
3. deSimone G, Devereux R, Chien S, et al. Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation. 1990;81:107-117.
4. Zarins C, Zatina M, Giddens D, et al. Shear stress regulation of artery lumen diameter in experimental atherogenesis. J Vasc Surg. 1987;5:413-420.
5. Klingel R, Fassbender C, Fassbender T, et al. Rheopheresis: rheologic, functional, and structural aspects. Ther Apho: 2000;4:348-357.
6. Sloop G. A unifying theory of atherogenesis. Med Hypotheses. 1996;47:321-325.
7. Lowe G. Blood rheology in arterial disease. Clin Sci. 1986;71:137-146.
8. Ajmani R, Rifkind J. Hemorheological changes during human aging. Gerontology. 1998;44:111-120.
9. Dintenfass L. Modifications of blood rheology during aging and age-related pathological conditions. Aging. 1989;1:99-125.
10. Koenig W, Ernst E. The possible role of hemorheology in atherothrombogenesis. Atherosclerosis. 1992;94:93-107.
11. Harkness J. Measurement of plasma viscosity. In: Lowe G, Barbanei J, Forbes C, eds. Clinical Aspects of Blood Viscosity and Cell Deformability. Berlin, Germany: Springer-Verlag; 1981:79-87.
12. Lowe G, Drummond M, Lorimer A, et al. Relation between extent of coronary artery disease and blood viscosity. Brit Med J. 1980;290:673-674.
13. Junker R, Heinrich J, Ulbrich H, et al. Relationship between plasma viscosity and the severity of coronary heart disease. Arterioscler Thromb Vasc Biol. 1998;18:870-875.
14. Neumann F, Katus H, Hoberg E, et al. Increased plasma viscosity and erythrocyte aggregation: indicators of an unfavourable clinical outcome in patients with unstable angina pectoris. Brit Heart J. 1991;66:425-430.
15. Rim S-J, Leong-Poi H, Lindner J, et al. Decrease in coronary blood flow reserve during hyperlipidemia is secondary to an increase in blood viscosity. Circulation. 2001;104:2704-2709.
16. Jay R, Rampling M, Betteridge D. Abnormalities of blood rheology in familial hypercholesterolaemia: effects of treatment. Atherosclerosis. 1990;85:249-256.
17. Ruhenstroth-Bauer G, Mossmer J, Ottl J, et al. Highly significant negative correlations between erythrocyte aggregation value and serum concentrations of high density lipoprotein cholesterol in a sample from a normal population and in patients with coronary heart disease. Eur J Clin Invest. 1987;17:275-279.
18. Danesh J, Collins R, Peto R, et al. Haematrocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Eur Heart J. 2000;21:515-520.
19. Iannuzzi A, Bianciardi G, Faccenda F, et al. Correction of ery throcyte shape abnormalities in familial hypercholesterolemia after LDL-apheresis: does it influence cerebral hemodynamics? Heart Vessels. 1997;12:234-240.
20. Martinez M, Vaya A, Marti R, et al. Erythrocyte membrane cholesterol/phospholipid changes and hemorheological modifications in familial hypercholesterolemia treated with lovastatin. Thromb Res. 1996;83:375-388.
21. Lees R, Holmes N, Stadler R, et al. Treatment of hypercholesterolemia with heparin-induced extracorporeal low-density lipoprotein precipitation (HELP). J Clin Apheresis. 1996;11: 132-137.
22. Seidel D. H.E.L.P.: apheresis therapy in the treatment of severe hypercholesterolemia: 10 years of clinical experience. Artif Organs. 1996;20:303-310.
23. Fadul J, Linde T, Sandhagen B, et al. Effects of extracorporeal hemapheresis therapy on blood rheology. J Clin Apheresis. 1997; 12:183-186.
24. Moriarty P, Gibson C, Kensey K, et al. LDL apheresis and its effect on whole blood viscosity. Paper presented at: 3rd Annual Conference on Arteriosclerosis, Thrombosis, and Vascular Biology. April 6-8, 2002; Salt Lake City, UT
25. Rubba P, Iannuzzi A, Postiglione A, et al. Hemodynamic changes in the peripheral circulation after repeat low density lipoprotein apheresis in familial hypercholesterolemia. Circulation. 1990;81:610-616.
26. Grutzmacher P, Landgraf H, Esser R, et al. In vivo rheologic effects of lipid apheresis techniques: comparison of dextran sulfate LDL adsorption and heparin-induced LDL precipitation. ASAIO Transactions. 1990;36:M327-M330.
27. Kulschar R, Engelmann B, Brautigam C, et al. Fast transmission of alterations in plasma phosphatidylcholine/sphingomyelin ration and lyso phosphatidylcholine levels into changes of red blood cell membrane phospholipid composition after low density lipoprotein apheresis. Eur J Clin Invest. 1995;25:258-265.
28. Tamai O, Matsuoka H, Itabe H, et al. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation. 1997;95:76-82.
29. Mellwig K, Bailer D, Gleichmann U, et al. Improvement of coronary vasodilatation capacity through single LDL apheresis. Atherosclerosis. 1998;139:173-178.
30. Park J, Mrowietz C, Schuler S, et al. Cutaneous microcirculation in cardiac allograft recipients with severe hypercholesterolemia before, during, and after the first HELP apheresis. Appl Cardiopulm Pathophysiol. 2000;9:19-25.
31. Walzl M, Valetitsch H, Walzl B, et al. Improved cerebral blood flow in patients treated by a single heparin-induced extracorporeal LDL precipitation (HELP). Clin Hemorheol. 1994;14:27-35.
32. Pfefferkorn T, Knupel H, Jaeger B, et al. Increased cerebral CO2 reactivity after heparin-mediated extracorporeal LDL precipitation (HELP) in patients with coronary heart disease and hyperlipidemia. Stroke. 1999;30:1802-1806.